NeoGenomics, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for NeoGenomics, Inc. (NEO) is 700.50M

According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 700.50M. This represents a change of 27.71% compared to the average of 548.52M of the last 4 quarters.

NeoGenomics, Inc. (NEO) Historical Enterprise Value (quarterly & annually)

How has NEO Enterprise Value performed in the past?

The mean historical Enterprise Value of NeoGenomics, Inc. over the last ten years is 613.83M. The current 700.50M Enterprise Value has changed 11.31% with respect to the historical average. Over the past ten years (40 quarters), NEO's Enterprise Value was at its highest in in the September 2021 quarter at 1.43B. The Enterprise Value was at its lowest in in the September 2016 quarter at 162.89M.

NeoGenomics, Inc. (NEO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeoGenomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeoGenomics, Inc. (NEO) Average Enterprise Value

How has NEO Enterprise Value performed in the past?

The current Enterprise Value of NeoGenomics, Inc. (NEO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

NeoGenomics, Inc. (NEO) Enterprise Value vs. Peers

How is NEO’s Enterprise Value compared to its peers?

NeoGenomics, Inc.’s Enterprise Value is greater than Exagen Inc. (108.94M), greater than MDxHealth S.A. (86.64M), greater than Stereotaxis, Inc. (120.92M), greater than Aclaris Therapeutics, Inc. (688.40M), greater than Quanterix Corporation (158.37M), greater than Sagimet Biosciences Inc. (192.79M), greater than Sanara MedTech Inc. (311.98M), greater than Arcturus Therapeutics Holdings Inc. (-22818430.00), greater than Humacyte, Inc. (122.29M), greater than Alpha Teknova, Inc. (276.28M),

Build a custom stock screener for NeoGenomics, Inc. (NEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeoGenomics, Inc. (NEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.